본문 바로가기
KERD
논문KCI 등재

Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

The cell ecology and spatial niche implicated in the dynamic and sequential process of lung adenocarcinoma (LUAD) from adenocarcinoma in situ (AIS) to minimally invasive adenocarcinoma (MIA) and subsequent invasive adenocarcinoma (IAC) have not yet been elucidated. Here, we performed an integrative analysis of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to characterize the cell atlas of the invasion trajectory of LUAD. We found that the UBE2C + cancer cell subpopulation constantly increased during the invasive process of LUAD with remarkable elevation in IAC, and its spatial distribution was in the peripheral cancer region of the IAC, representing a more malignant phenotype. Furthermore, analysis of the TME cell type subpopulation showed a constant decrease in mast cells, monocytes, and lymphatic endothelial cells, which were implicated in the whole process of invasive LUAD, accompanied by an increase in NK cells and MALT B cells from AIS to MIA and an increase in Tregs and secretory B cells from MIA to IAC. Notably, for AIS, cancer cells, NK cells, and mast cells were colocalized in the cancer region; however, for IAC, Tregs colocalized with cancer cells. Finally, communication and interaction between cancer cells and TME cell-induced constitutive activation of TGF-β signaling were involved in the invasion of IAC. Therefore, our results reveal the specific cellular information and spatial architecture of cancer cells and TME subpopulations, as well as the cellular interaction between them, which will facilitate the identification and development of precision medicine in the invasive process of LUAD from AIS to IAC.

Abstract

The cell ecology and spatial niche implicated in the dynamic and sequential process of lung adenocarcinoma (LUAD) from adenocarcinoma in situ (AIS) to minimally invasive adenocarcinoma (MIA) and subsequent invasive adenocarcinoma (IAC) have not yet been elucidated. Here, we performed an integrative analysis of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to characterize the cell atlas of the invasion trajectory of LUAD. We found that the UBE2C + cancer cell subpopulation constantly increased during the invasive process of LUAD with remarkable elevation in IAC, and its spatial distribution was in the peripheral cancer region of the IAC, representing a more malignant phenotype. Furthermore, analysis of the TME cell type subpopulation showed a constant decrease in mast cells, monocytes, and lymphatic endothelial cells, which were implicated in the whole process of invasive LUAD, accompanied by an increase in NK cells and MALT B cells from AIS to MIA and an increase in Tregs and secretory B cells from MIA to IAC. Notably, for AIS, cancer cells, NK cells, and mast cells were colocalized in the cancer region; however, for IAC, Tregs colocalized with cancer cells. Finally, communication and interaction between cancer cells and TME cell-induced constitutive activation of TGF-β signaling were involved in the invasion of IAC. Therefore, our results reveal the specific cellular information and spatial architecture of cancer cells and TME subpopulations, as well as the cellular interaction between them, which will facilitate the identification and development of precision medicine in the invasive process of LUAD from AIS to IAC.

참고문헌 (69)

  1. Nicholson, A. G., "The 2021 WHO classification of lung tumors: impact of advances since 2015.", J. Thorac. Oncol, 17, pp.362~387 (2022)
  2. Jia, M., "Clinicopathologic features and genetic alterations in adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung : long-term follow-up study of 121 Asian Patients", Ann. Surg. Oncol, 27, pp.3052~3063 (2020)
  3. Yotsukura, M., "Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung", J. Thorac. Oncol, 16, pp.1312~1320 (2021)
  4. Zhang, C., "Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma", J. Thorac. Oncol, 14, pp.1912~1923 (2019)
  5. Chen, H., "Genomic and immune profiling of pre-invasive lung adenocarcinoma", Nat. Commun, 10, pp.5472~ (2019)
  6. Hu, X., "Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma", Nat. Commun, 10, pp.2978~ (2019)
  7. Li, Y., "Genomic characterisation of pulmonary subsolid nodules : mutational landscape and radiological features", Eur. Respir. J, 55, pp.1901409~ (2020)
  8. Lu, T., "Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules", Cell Discov, 6, pp.69~ (2020)
  9. Xing, X., "Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing", Sci. Adv, 7, pp.eabd9738~ (2021)
  10. Wang, Z., "Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing", Nat. Commun, 12, pp.6500~ (2021)
  11. Hegde, P. S., "Top 10 challenges in cancer immunotherapy", Immunity, 52, pp.17~35 (2020)
  12. Sinjab, A., "Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing", Cancer Disco, 11, pp.2506~2523 (2021)
  13. Wang, Y., "Single-cell analysis reveals spatial heterogeneity of immune cells in lung adenocarcinoma", Front. Cell. Dev. Biol, 9, pp.638374~ (2021)
  14. Stahl, P. L., "Visualization and analysis of gene expression in tissue sections by spatial transcriptomics", Science, 353, pp.78~82 (2016)
  15. Berglund, E., "Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity", Nat. Commun, 9, pp.2419~ (2018)
  16. Moncada, R., "Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas", Nat. Biotechnol, 38, pp.333~342 (2020)
  17. Wu, Y., "Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level", Cancer Disco, 12, pp.134~153 (2022)
  18. Dong, R., "Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma", Cancer Cell, 38, pp.716~733 (2020)
  19. Stuart, T., "Comprehensive integration of single-cell data", Cell, 177, pp.1888~1902 (2019)
  20. Hafemeister, C., "Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression", Genome Biol, 20, pp.296~ (2019)
  21. Vincent, D. B., "Fast unfolding of communities in large networks", Journal of Statistical Mechanics: Theory and Experiment, 2008 (2008)
  22. "Umap: uniform manifold approximation and projection for dimension reduction" (2018)[URL]
  23. Martin-Gayo, E., "A reproducibility-based computational framework identifies an inducible, enhanced antiviral state in dendritic cells from HIV-1 elite controllers", Genome Biol, 19, pp.10~ (2018)
  24. Li, Q., "Measuring reproducibility of highthroughput experiments", Ann. Appl. Stat, 5, pp.1752~1779 (2011)
  25. Li, B., "Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq", Nat. Methods, 17, pp.793~798 (2020)
  26. Subramanian, A., "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc. Natl Acad. Sci. USA, 102, pp.15545~15550 (2005)
  27. Hanzelmann, S., "GSVA: gene set variation analysis for microarray and RNA-seq data", BMC Bioinforma, 14, pp.7~ (2013)
  28. Aibar, S., "SCENIC: single-cell regulatory network inference and clustering", Nat. Methods, 14, pp.1083~1086 (2017)
  29. Huynh-Thu, V. A., "Inferring regulatory networks from expression data using tree-based methods", PLoS One, 5, pp.e12776~ (2010)
  30. Ritchie, M. E., "limma powers differential expression analyses for RNAsequencing and microarray studies", Nucleic Acids Res, 43, pp.e47~ (2015)
  31. Trapnell, C., "The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells", Nat. Biotechnol, 32, pp.381~386 (2014)
  32. Qiu, X., "Single-cell mRNA quantification and differential analysis with Census", Nat. Methods, 14, pp.309~315 (2017)
  33. Qiu, X., "Reversed graph embedding resolves complex single-cell trajectories", Nat. Methods, 14, pp.979~982 (2017)
  34. Jin, S., "Inference and analysis of cell-cell communication using CellChat", Nat. Commun, 12, pp.1088~ (2021)
  35. Browaeys, R., "NicheNet : modeling intercellular communication by linking ligands to target genes", Nat. Methods, 17, pp.159~162 (2020)
  36. Cable, D. M., "Robust decomposition of cell type mixtures in spatial transcriptomics", Nat. Biotechnol, 40, pp.517~526 (2022)
  37. Cao, J., "The single-cell transcriptional landscape of mammalian organogenesis", Nature, 566, pp.496~502 (2019)
  38. Kueckelhaus, J., "Inferring spatially transient gene expression pattern from spatial transcriptomic studies", bioRxiv, ~ (2020)
  39. Cortal, A., "Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID", Nat. Biotechnol, 39, pp.1095~1102 (2021)
  40. Lambrechts, D., "Phenotype molding of stromal cells in the lung tumor microenvironment", Nat. Med, 24, pp.1277~1289 (2018)
  41. Maynard, A., "Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing", Cell, 182, pp.1232~1251 (2020)
  42. Wu, F., "Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer", Nat. Commun, 12, pp.2540~ (2021)
  43. Morikawa, T., "UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy", Int. J. Clin. Exp. Pathol, 6, pp.1367~1374 (2013)
  44. Mo, C. H., "The clinicopathological significance of UBE2C in breast cancer : a study based on immunohistochemistry, microarray and RNA-sequencing data", Cancer Cell Int, 17, pp.83~ (2017)
  45. Xu, X., "Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma", Proc. Natl Acad. Sci. USA, 109, pp.4910~4915 (2012)
  46. Irvine, A. F., "Characterising cancerassociated fibroblast heterogeneity in non-small cell lung cancer : a systematic review and meta-analysis", Sci. Rep, 11, pp.3727~ (2021)
  47. Wang, Y., "Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5", J. Immunol, 201, pp.278~295 (2018)
  48. Lou, E., "Cellular and molecular networking within the ecosystem of cancer cell communication via tunneling nanotubes", Front. Cell. Dev. Biol, 6, pp.95~ (2018)
  49. Armingol, E., "Deciphering cell-cell interactions and communication from gene expression", Nat. Rev. Genet, 22, pp.71~88 (2021)
  50. Pallasch, F. B., "Angiotensin inhibition, TGF-beta and EMT in cancer", Cancers (Basel), 12, pp.2785~ (2020)
  51. Derynck, R., "TGFbeta biology in cancer progression and immunotherapy", Nat. Rev. Clin. Oncol, 18, pp.9~34 (2021)
  52. Pickup, M., "The roles of TGFbeta in the tumour microenvironment", Nat. Rev. Cancer, 13, pp.788~799 (2013)
  53. Tumeh, P. C., "PD-1 blockade induces responses by inhibiting adaptive immune resistance", Nature, 515, pp.568~571 (2014)
  54. Teng, M. W., "Classifying cancers based on T-cell infiltration and PD-L1", Cancer Res, 75, pp.2139~2145 (2015)
  55. Liu, Y., "UBE2C is upregulated by estrogen and promotes epithelialmesenchymal transition via p53 in endometrial cancer", Mol. Cancer Res, 18, pp.204~215 (2020)
  56. Chiang, A. J., "UBE2C drives human cervical cancer progression and is positively modulated by mTOR", Biomolecules, 11, pp.37~ (2021)
  57. Li, J., "Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1", Biochem. Biophys. Res. Commun, 523, pp.434~440 (2020)
  58. Guo, J., "Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression", Oncogenesis, 7, pp.49~ (2018)
  59. Thrane, K., "Spatially resolved transcriptomics enables dissection of genetic heterogeneity in stage III cutaneous malignant melanoma", Cancer Res, 78, pp.5970~5979 (2018)
  60. Barresi, V., "Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma", J. Clin. Pathol, 64, pp.6~12 (2011)
  61. Yang, Y., "Combined consideration of tumor-associated immune cell density and immune checkpoint expression in the peritumoral microenvironment for prognostic stratification of non-small-cell lung cancer patients", Front Immunol, 13, pp.811007~ (2022)
  62. Chen, Z., "Non-small-cell lung cancers : a heterogeneous set of diseases", Nat. Rev. Cancer, 14, pp.535~546 (2014)
  63. Rowbotham, S. P., "Diverse cells at the origin of lung adenocarcinoma", Proc. Natl Acad. Sci. USA, 111, pp.4745~4746 (2014)
  64. Sarode, P., "Epithelial cell plasticity defines heterogeneity in lung cancer", Cell. Signal, 65, pp.109463~ (2020)
  65. Sutherland, K. D., "Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma", Proc. Natl Acad. Sci. USA, 111, pp.4952~4957 (2014)
  66. Mainardi, S., "Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma", Proc. Natl Acad. Sci. USA, 111, pp.255~260 (2014)
  67. Zhang, M., "Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing", Gut, 70, pp.464~475 (2021)
  68. Young, M. D., "Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors", Science, 361, pp.594~599 (2018)
  69. Wu, Y. Y., "SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer", Oncogene, 30, pp.3682~3693 (2011)

이 간행물의 다른 논문 (191건)